Lipo-C + B12 LC216 Blend Injectable 216mg/ml 10ml/vial 10vials 1kit

Description

Lipo-C Lipotropic Carnitine Injectable Metabolic Research

Compound Background

Lipo-C Oil is a sterile, high-potency parenteral formulation engineered to optimize systemic lipid metabolism through the synergistic integration of lipotropic agents and L-carnitine. L-carnitine facilitates the translocation of long-chain fatty acids across the inner mitochondrial membrane, a rate-limiting step in cellular energy production. Researchers utilize this oil-based nutrient matrix to investigate the modulation of metabolic flux and the preservation of hepatic homeostasis in advanced biological research models. Unlike Lipo-B, which prioritizes methylation pathways, Lipo-C provides enhanced support for mitochondrial beta-oxidation and intracellular energy transport.

Specification Sheet

• Lipo-C + B12 Formula Breakdown (per mL) Core Components:
  L-Carnitine 20mg
  L-Arginine 20mg
  Methionine 25mg
  Inositol 50mg
  Choline 50mg
  B6 (Pyridoxine) 25mg
  B5(Dexpanthenol) 25mg
  B12 (Methy|cobalamin) 1mg
• CAS Numbers: 63-68-3 (M), 87-89-8 (I), 67-48-1 (C), 541-15-1 (LC)
• Purity: >99% composite purity confirmed via HPLC-UV and GC/MS
• Appearance: Clear, pink to light red viscous solution
• Carrier: Pharmaceutical-grade sterile oil carrier optimized for sustained release

Mechanism Overview

The pharmacology of Lipo-C Oil is defined by its role as a required cofactor system for fatty acid utilization and hepatic lipid export. L-carnitine binds to carnitine palmitoyltransferase I (CPT1) to enable the transport of acyl-CoA molecules into the mitochondrial matrix for ATP production. Choline promotes the synthesis of phosphatidylcholine, which is essential for the assembly and secretion of Very Low-Density Lipoproteins (VLDL) from the liver. Methionine facilitates the hepatic export of lipids by serving as a precursor for S-adenosylmethionine (SAMe), the primary methyl donor in phospholipid metabolism. Binding kinetics show that parenteral administration increases the bioavailability of L-carnitine by 80-90% compared to oral models, where intestinal saturation limits uptake. Quantitatively, L-carnitine exhibits a terminal plasma half-life of approximately 17.4 hours (±1.2 hours) in research models, necessitating consistent titration to maintain elevated metabolic activity.

Research Observations

• Enhanced Lipolytic Rate: Investigators observe accelerated reduction in adipose tissue volume when utilized in conjunction with caloric restriction.
• Elevated Mitochondrial Energy: Based on community feedback, effects include a significant increase in subjective stamina and recovery during high-intensity research phases.
• Hepatic Lipid Clearance: Published research indicates improved markers of liver health and reduced intrahepatic triglyceride accumulation.
• Nutrient Partitioning: Observed effects in research models include a shift in substrate utilization toward fatty acid oxidation, sparing glycogen stores.
• Metabolic Optimization: Users report enhanced synergy when co-administered with GLP-1 agonists like Semaglutide to mitigate muscle fatigue.

In Brief:
Lipo-C Oil remains a high-precision research tool for studying the intersection of mitochondrial fatty acid transport and systemic lipid regulation.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.